Maintenance Treatment Using Abatacept with Dose Reduction after Achievement of Low Disease Activity in Patients with Rheumatoid Arthritis (MATADOR) - a Prospective, Multicentered, Single Arm Clinical Trial

被引：0

作者：

Yasuda, Shinsuke ^{[1
]}

Ohmura, Kazumasa ^{[1
]}

Kanazawa, Hiroshi ^{[2
]}

Kurita, Takashi ^{[1
]}

Kon, Yujiro ^{[3
]}

Ishii, Tomonori ^{[4
]}

Jodo, Satoshi ^{[5
]}

Tanimura, Kazuhide ^{[6
]}

Minami, Michio ^{[7
]}

Izumiyama, Tomomasa ^{[8
]}

Matsumoto, Takumi ^{[9
]}

Amasaki, Yoshiharu ^{[10
]}

Suzuki, Yoko ^{[11
]}

Kasahara, Hideki ^{[12
]}

Yamauchi, Naofumi ^{[13
]}

Tsutsumi, Akito ^{[3
]}

Takemori, Hiromitsu ^{[2
]}

Koike, Takao ^{[14
]}

Atsumi, Tatsuya ^{[1
]}

机构：

[1] Hokkaido Univ, Grad Sch Med, Div Rheumatol Endocrinol & Nephrol, Sapporo, Hokkaido, Japan

[2] Aomori Prefectural Cent Hosp, Dept Rheumatol, Aomori, Japan

[3] Takikawa Municipal Hosp, Dept Internal Med, Takikawa, Hokkaido, Japan

[4] Tohoku Univ, Grad Sch Med, Dept Hematol & Rheumatol, Sendai, Miyagi, Japan

[5] Tomakomai City Hosp, Dept Internal Med, Tomakomai, Japan

[6] Hokkaido Med Ctr Rheumat Dis, Sapporo, Hokkaido, Japan

[7] Hokkaido Orthopaed Mem Hosp, Dept Rheumatol & Orthopaed Surg, Sapporo, Hokkaido, Japan

[8] Higashisendai Rheumat Dis Clin, Sendai, Miyagi, Japan

[9] Kin Ikyo Chuo Hosp, Div Rheumatol, Sapporo, Hokkaido, Japan

[10] Tonan Hosp, Ctr Rheumat Dis, Sapporo, Hokkaido, Japan

[11] Izumi Himawari Clin, Sendai, Miyagi, Japan

[12] NTT Sapporo Med Ctr, Rheumatol, Sapporo, Hokkaido, Japan

[13] Sapporo Kiyota Hosp, Sapporo, Hokkaido, Japan

[14] NTT Sapporo Med Ctr, Sapporo, Hokkaido, Japan

来源：

ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1601

引用

页数：2

共 50 条

[21] MEDICATION INTERVAL OF ADALIMUMAB FOR RHEUMATOID ARTHRITIS PATIENTS MIGHT BE EXTENDED AFTER THE ACHIEVEMENT OF LOW DISEASE ACTIVITY -KABUKI STUDY-
Okano, T.
Inui, K.
Tada, M.
Sugioka, Y.
Mamoto, K.
Koike, T.
Nakamura, H.
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 471 - 471
[22] What Are the Benefits of Treating Rheumatoid Arthritis Patients to Remission After Achieving Low Disease Activity in Clinical Practice?
Zhao, Jing
Sbarigia, Urbano
Kwong, Jackie
Naik, Chinmayi
Zazzetti, Federico
Shadick, Nancy
Weinblatt, Michael
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3559 - 3561
[23] IMPORTANCE OF BOTH DISEASE ACTIVITY AT 12 WEEKS AND CLINICAL RESPONSE UP TO 12 WEEKS TO PREDICT ACHIEVEMENT OF LOW DISEASE ACTIVITY AT 52 WEEKS DURING ABATACEPT TREATMENT IN BIOLOGICS-SWITCHING PATIENTS WITH RHEUMATOID ARTHRITIS: A MULTICENTER OBSERVATIONAL COHORT STUDY IN JAPAN
Kojima, T.
Takahashi, N.
Kaneko, A.
Kida, D.
Hirano, Y.
Fujibayashi, T.
Yabe, Y.
Takagi, H.
Oguchi, T.
Miyake, H.
Kato, T.
Watanabe, T.
Hayashi, M.
Shioura, T.
Kanayama, Y.
Funahashi, K.
Asai, S.
Yoshioka, Y.
Terabe, K.
Takemoto, T.
Asai, N.
Ishiguro, N.
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 235 - +
[24] THE RELATIONSHIP BETWEEN ADHERENCE TO A TREAT-TO-TARGET APPROACH FOR CLINICAL CARE OF US PATIENTS WITH RHEUMATOID ARTHRITIS AND ACHIEVEMENT OF LOW DISEASE ACTIVITY
Harrold, L. R.
Reed, G. W.
John, A.
Barr, C. J.
Saunders, K. C.
Soe, K.
Magner, R.
Greenberg, J. D.
Kremer, J. M.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 199 - 200
[25] Achievement of Remission and Low Disease Activity Definitions in Patients with Rheumatoid Arthritis in Clinical Practice: Results from the NOR-DMARD Study
Uhlig, Till
Lie, Elisabeth
Norvang, Vibeke
Lexberg, Ase Stavland
Rodevand, Erik
Kroll, Frode
Kalstad, Synove
Olsen, Inge C.
Kvien, Tore K.
JOURNAL OF RHEUMATOLOGY, 2016, 43 (04) : 716 - 723
[26] Failure of low-dose intravenous immunoglobulin therapy to suppress disease activity in patients with treatment-refractory rheumatoid arthritis
Kanik, KS
Yarboro, CH
Naparstek, Y
Plotz, PH
Wilder, RL
ARTHRITIS AND RHEUMATISM, 1996, 39 (06): : 1027 - 1029
[27] THE IMPACT OF PATIENTS REPORTED FLARES ON FUNCTIONAL IMPAIRMENT IN RHEUMATOID ARTHRITIS PATIENTS WITH LOW-DISEASE ACTIVITY: A PROSPECTIVE COHORT STUDY BASED ON THE AMBRA TRIAL
Kuettel, D.
Christensen, R.
Primdahl, J.
Horslev-Petersen, K.
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 977 - 977
[28] DISCONTINUATION OF BARICITINIB AFTER ACHIEVING LOW DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL PRACTICE; A MULTICENTER OBSERVATIONAL STUDY.
Torikai, E.
Hirano, Y.
Suzuki, D.
Kanayama, Y.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 647 - 647
[29] Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial
Burmester, Gerd R.
Buttgereit, Frank
Bernasconi, Corrado
Alvaro-Gracia, Jose M.
Castro, Nidia
Dougados, Maxime
Gabay, Cem
van Laar, Jacob M.
Nebesky, Jan Michael
Pethoe-Schramm, Attila
Salvarani, Carlo
Donath, Marc Y.
John, Markus R.
LANCET, 2020, 396 (10246): : 267 - 276
[30] FLARE RISK AFTER DISCONTINUING LONG-TERM METHOTREXATE TREATMENT IN PATIENTS HAVING RHEUMATOID ARTHRITIS WITH LOW DISEASE ACTIVITY
Nam, S. H.
Lee, J. S.
Choi, S. J.
Seo, W. J.
Oh, J. S.
Hong, S.
Kim, Y. G.
Lee, C. K.
Yoo, B.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1402 - 1403

← 1 2 3 4 5 →